🔎 Trials Near Me

Home › Atopic Dermatitis (Eczema) › Maryland

Pag-aaral pangklinika para sa Atopic Dermatitis (Eczema) sa Maryland

14 pag-aaral para sa Atopic Dermatitis (Eczema) ang naghahanap ng mga kalahok sa mga site sa Maryland.

Mga Lungsod sa Maryland

Opisyal na teksto ng pag-aaral (English)

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07262983

Effects of Treatments on Atopic Dermatitis

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 50 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01631617

Natural History and Genetics of Food Allergy and Related Conditions

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 99 Years · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT02504853

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

  • U.S. Dermatology Partners Rockville, Rockville
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 89 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07645820

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  • Maryland Laser Skin and Vein, Hunt Valley
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07783425

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT00605878

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

  • Investigational Site, Rockville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07003425

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT04864886

Cardamom and Topical Roseomonas in Atopic Dermatitis

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06096857

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 3 hanggang 100 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06732414

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • Chesapeake Clinical Research, Inc, Pasadena
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599813

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 3 hanggang 21 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT03835767

Registry for Systemic Eczema Treatments

  • Johns Hopkins University, Baltimore
Nagre-recruitObservasyonal na pag-aaral
Edad 1 hanggang 26 · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT06136767

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 7098, Columbia
  • Galderma Investigational Site 8012, Glenn Dale
  • Galderma Investigational Site 7068, Rockville
Nagre-recruitObservasyonal na pag-aaral
Edad 12 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06988605

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.